<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="6bbc032a-3cc4-4b1d-8124-1784214a2821"><labelDrug name="Benicar HCT"><Normalization><mmtx cui="C1330085" preferredWord="Benicar HCT" semType="phsu, orch"/></Normalization></labelDrug><generic name="olmesartan medoxomil-hydrochlorothiazide"/><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1" text="BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) tablet, film coated" type="negative"><entity charOffset="0:11" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.0" text="benicar hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1330085" phraseText="BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide" preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="13:33" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.1" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="34:53" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.1.e.2"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.4" text="Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs." type="negative"><entity charOffset="131:142" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.4.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.4.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.4.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.4.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5" lineNumber="9" text="Do not co-administer aliskiren with BENICAR HCT in patients with diabetes." type="regular"><entity charOffset="0:20" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with BENICAR HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.3" text="BENICAR HCT" type="Drug"><Normalization><mmtx cui="C1330085" phraseText="aliskiren with BENICAR HCT" preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="65:73" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.0"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.4" ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.5.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="168:179" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.2" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.14.e.2"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23" text="No teratogenic effects were observed when 1.6:1 combinations of olmesartan medoxomil and hydrochlorothiazide were administered to pregnant mice at oral doses up to 1625 mg/kg/day (122 times the maximum recommended human dose [MRHD] on a mg/m2 basis) or pregnant rats at oral doses up to 1625 mg/kg/day (280 times the MRHD on a mg/m2 basis). " type="negative"><entity charOffset="333:338" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="89:108" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="243:248" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.2" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="64:84" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.3" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="1 combinations of olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.23.e.2"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25" text="The no observed effect dose for developmental toxicity in rats, 162.5 mg/kg/day, is about 28 times, on a mg/m2 basis, the MRHD of BENICAR HCT  (40 mg olmesartan medoxomil /25 mg hydrochlorothiazide/day)." type="negative"><entity charOffset="111:116" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="150:170" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.1" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="of BENICAR HCT  (40 mg olmesartan medoxomil /25 mg hydrochlorothiazide/day" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="178:197" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="of BENICAR HCT  (40 mg olmesartan medoxomil /25 mg hydrochlorothiazide/day" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="130:141" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.3" text="benicar hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1330085" phraseText="of BENICAR HCT  (40 mg olmesartan medoxomil /25 mg hydrochlorothiazide/day" preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.3"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.25.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29" lineNumber="27" text="In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with BENICAR HCT, as with any angiotensin receptor blocker. " type="regular"><entity charOffset="144:153" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="treated with high doses of diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="156:179" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.1" text="symptomatic hypotension" type="Specific_Interaction"/><entity charOffset="225:236" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.3" text="BENICAR HCT" type="Drug"><Normalization><mmtx cui="C1330085" phraseText="with BENICAR HCT," preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="250:278" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.4" text="angiotensin receptor blocker" type="Drug_Class"><Normalization><mmtx cui="C0003018" phraseText="as with any angiotensin receptor blocker." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="64:71|80:97" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.6" text="volume- depleted patients" type="SPAN"/><entity charOffset="75:97" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.7" text="salt-depleted patients" type="SPAN"/><drugClassMembership drug="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.3" drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.4"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.1"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.6, Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.7" ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.29.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47" lineNumber="49" text="Lithium generally should not be given with thiazides (see PRECAUTIONS: Drug Interactions; " type="regular"><entity charOffset="0:7" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.0" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="43:52" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.1" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="25:37" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.2" text="not be given" type="Caution_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.1" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.47.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.48" text="Hydrochlorothiazide, Lithium)." type="negative"><entity charOffset="0:19" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.48.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="21:28" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.48.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="Lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.48.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.48.e.1"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.50" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="23:34" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.50.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="a sulfonamide," preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.50.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.50.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.50.e.0"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.58" text="Olmesartan medoxomil-hydrochlorothiazide" type="negative"><entity charOffset="0:20" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.58.e.0" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="Olmesartan medoxomil-hydrochlorothiazide" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="21:40" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.58.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Olmesartan medoxomil-hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.58.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.58.e.1"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59" text="In a double-blind clinical trial of various doses of olmesartan medoxomil and hydrochlorothiazide, the incidence of hypertensive patients who developed hypokalemia (serum potassium &lt;3.4 mEq/L) was 2.1%; " type="negative"><entity charOffset="171:180" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="78:97" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="53:73" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.2" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="of olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.59.e.1"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.63" text="Periodic determinations of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. " type="negative"><entity charOffset="33:45" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.63.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="Periodic determinations of serum electrolytes to" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="65:76" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.63.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="possible electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.63.e.0" e2=""/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.64" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: hyponatremia, hypochloremic alkalosis and hypokalemia. " type="negative"><entity charOffset="90:101" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.64.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.64.e.1" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.64.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.64.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75" lineNumber="76" text="In diabetic patients dosage adjustments of insulin or oral hypoglycemic agents may be required. " type="irregular"><entity charOffset="43:50" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.0" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="54:78" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.1" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="3:20" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.2" text="diabetic patients" type="SPAN"/><entity charOffset="21:39" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.3" text="dosage adjustments" type="Caution_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.3"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.74" text="Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy."><entity charOffset="88:96" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.74.e.0" text="thiazide" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy." preferredWord="Thiazides" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.75.e.0"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.82" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="0:9" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.82.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="31:38" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.82.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.82.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.82.e.1"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.83" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="0:9" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.83.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="63:70" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.83.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="slight elevation of serum calcium" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.83.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.83.e.1"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. " type="negative"><entity charOffset="41:52" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="158:178" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.1" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="treated with olmesartan medoxomil." preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="53:64" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.2" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.88.e.1"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89" text="In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. " type="negative"><entity charOffset="87:98" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend upon the activity of the renin-angiotensin-aldosterone system" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="220:252" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.1" text="angiotensin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor antagonists" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="75:86" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend upon the activity of the renin-angiotensin-aldosterone system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="175:215" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.3" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.3"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.89.e.3"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.92" text="In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. " type="negative"><entity charOffset="132:136" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.92.e.0" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="blood urea nitrogen (BUN)" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><entity charOffset="14:28" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.92.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.92.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.92.e.0"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99" text="No significant drug interactions were reported in studies in which olmesartan medoxomil was co-administered with hydrochlorothiazide, digoxin or warfarin in healthy volunteers. " type="negative"><entity charOffset="113:132" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="co-administered with hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="67:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.1" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="in which olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="145:153" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.2" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin in healthy volunteers." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="134:141" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.3" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.3"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.3"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.99.e.2"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100" text="The bioavailability of olmesartan was not significantly altered by the co-administration of antacids [Al(OH)3/Mg(OH)2]. " type="negative"><entity charOffset="23:33" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.0" text="olmesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C1098320" phraseText="The bioavailability of olmesartan" preferredWord="olmesartan" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="92:100" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.1" text="antacids" type="Biomedical_Entity"><Normalization><mmtx cui="C0003138" phraseText="altered by the co-administration of antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="863"/></Normalization></entity><entity charOffset="110:117" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.2" text="mg 2" type="Biomedical_Entity"><Normalization><mmtx cui="C2346927" phraseText="[Al(OH)3/Mg(OH)2" preferredWord="Magnesium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.100.e.2"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.103" text="Dual Blockade of the Renin- Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.103.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin- Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="28:39" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.103.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin- Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.103.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.103.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104" lineNumber="103" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1"/></relation><relation type="hasObject"><labelDrug text="Benicar HCT"/><normalization><mmtx><preferredWord>Benicar HCT</preferredWord><phraseText>aliskiren with BENICAR HCT</phraseText><cuiCode>C1330085</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1"/></relation><relation type="hasObject"><labelDrug text="Benicar HCT"/><normalization><mmtx><preferredWord>Benicar HCT</preferredWord><phraseText>aliskiren with BENICAR HCT</phraseText><cuiCode>C1330085</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.ddi.3"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1"/></relation><relation type="hasObject"><labelDrug text="Benicar HCT"/><normalization><mmtx><preferredWord>Benicar HCT</preferredWord><phraseText>aliskiren with BENICAR HCT</phraseText><cuiCode>C1330085</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.ddi.4"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1"/></relation><relation type="hasObject"><labelDrug text="Benicar HCT"/><normalization><mmtx><preferredWord>Benicar HCT</preferredWord><phraseText>aliskiren with BENICAR HCT</phraseText><cuiCode>C1330085</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.104.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105" lineNumber="103" text="Closely monitor blood pressure, renal function and electrolytes in patients on Benicar HCT and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:90" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.2" text="Benicar HCT" type="Drug"><Normalization><mmtx cui="C1330085" phraseText="on Benicar HCT" preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="101:127" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.105.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106" lineNumber="105" text="Do not co-administer aliskiren with Benicar HCT in patients with diabetes (see CONTRAINDICATIONS). " type="regular"><entity charOffset="0:20" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Benicar HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.3" text="Benicar HCT" type="Drug"><Normalization><mmtx cui="C1330085" phraseText="aliskiren with Benicar HCT" preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="65:73" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.0"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.4" ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.106.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107" lineNumber="105" text="Avoid use of aliskiren with Benicar HCT in patients with renal impairment (GFR &lt;60ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:39" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.3" text="Benicar HCT" type="Drug"><Normalization><mmtx cui="C1330085" phraseText="with Benicar HCT" preferredWord="Benicar HCT" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="57:73" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.4" ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.107.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="0:38" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.0" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-Steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="88:104" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.1" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.2" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.108.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109" lineNumber="109" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including olmesartan medoxomil, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="20:27" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.0" text="elderly" type="SPAN"/><entity charOffset="29:44" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="92:118" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="141:147" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="159:185" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="192:227" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.6" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="239:259" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.7" text="olmesartan medoxomil" type="Drug"><Normalization><mmtx cui="C0386393" phraseText="olmesartan medoxomil," preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="275:306" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="327:346" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.4"/><drugClassMembership drug="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.7" drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.6"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.9"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.11"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.6"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.2, Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.1, Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.0" ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.6" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.109.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111" lineNumber="109" text="Monitor renal function periodically in patients receiving olmesartan medoxomil and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:78" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.2" text="olmesartan medoxomil" type="Drug"><Normalization><mmtx cui="C0386393" phraseText="olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="83:88" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.111.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112" lineNumber="111" text="The antihypertensive effect of angiotensin II receptor antagonists, including olmesartan medoxomil may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="120:126" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="137:163" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.1" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="31:66" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.3" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:98" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.4" text="olmesartan medoxomil" type="Drug"><Normalization><mmtx cui="C0386393" phraseText="olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="4:27|106:116" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.6" text="antihypertensive effect attenuated" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.1"/><drugClassMembership drug="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.4" drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.3"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.3" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.0" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.112.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114" lineNumber="115" text="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride reduces the systemic exposure and peak plasma concentration of olmesartan. " type="regular"><entity charOffset="29:57" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.0" text="bile acid sequestering agent" type="Drug_Class"><Normalization><mmtx cui="C2917673" phraseText="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride" preferredWord="Bile Acid [EPC]" semType="phsu"/><mmtx cui="C1254351" phraseText="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0360087" phraseText="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride" preferredWord="Bile agent" semType="phsu, orch"/><mmtx cui="C0001128" phraseText="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride" preferredWord="Acids" semType="chem"/><RxNorm RxCui="1540"/></Normalization></entity><entity charOffset="58:83" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.1" text="colesevelam hydrochloride" type="Drug"><Normalization><mmtx cui="C0541154" phraseText="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride" preferredWord="Colesevelam hydrochloride" semType="phsu, orch"/><mmtx cui="C0541154" phraseText="Concurrent administration of bile acid sequestering agent colesevelam hydrochloride" preferredWord="Colesevelam hydrochloride" semType="phsu, orch"/><RxNorm RxCui="141625"/></Normalization></entity><entity charOffset="147:157" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.3" text="olmesartan" type="Drug"><Normalization><mmtx cui="C0386393" phraseText="peak plasma concentration of olmesartan." preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><mmtx cui="C1098320" phraseText="peak plasma concentration of olmesartan." preferredWord="olmesartan" semType="phsu, orch"/><mmtx cui="C0386393" phraseText="peak plasma concentration of olmesartan." preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><mmtx cui="C1098320" phraseText="peak plasma concentration of olmesartan." preferredWord="olmesartan" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="84:113" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.4" text="reduces the systemic exposure" type="Decrease_Interaction"/><entity charOffset="84:95|118:143" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.6" text="reduces the peak plasma concentration" type="Decrease_Interaction"/><drugClassMembership drug="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.1" drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.0"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.4"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.6"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.114.e.4" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.115" text="Administration of olmesartan at least 4 hours prior to colesevelam hydrochloride decreased the drug interaction effect. " type="negative"><entity charOffset="18:28" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.115.e.0" text="olmesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="Administration of olmesartan" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="55:80" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.115.e.1" text="colesevelam hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0541154" phraseText="prior to colesevelam hydrochloride" preferredWord="Colesevelam hydrochloride" semType="phsu, orch"/><RxNorm RxCui="141625"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.115.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.115.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116" lineNumber="115" text="Consider administering olmesartan at least 4 hours before the colesevelam hydrochloride dose (see CLINICAL PHARMACOLOGY, Drug Interactions)." type="regular"><entity charOffset="9:22|51:57" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.0" text="administering before" type="Caution_Interaction"/><entity charOffset="23:33" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.2" text="olmesartan" type="Drug"><Normalization><mmtx cui="C0386393" phraseText="administering olmesartan at least 4 hours" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><mmtx cui="C1098320" phraseText="administering olmesartan at least 4 hours" preferredWord="olmesartan" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="62:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.3" text="colesevelam hydrochloride" type="Drug"><Normalization><mmtx cui="C0541154" phraseText="before the colesevelam hydrochloride dose" preferredWord="Colesevelam hydrochloride" semType="phsu, orch"/><RxNorm RxCui="141625"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.116.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" lineNumber="121" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="0:7" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.0" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.1" text="Barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="Barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.2" text="Narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="Narcotics   potentiation of orthostatic hypotension" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="54:77" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.3" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="Narcotics   potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.1"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.2"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120" lineNumber="123" text="Antidiabetic Drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.2" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.1" text="insulin" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.2" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.0" text="Antidiabetic Drugs oral agents" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:18|20:31" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.0" text="Antidiabetic Drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic Drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.1" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="47:64" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.5" text="dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.5"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121" lineNumber="125" text="Other Antihypertensive Drugs   additive effect or potentiation." type="irregular"><entity charOffset="31:62" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121.e.0" text="additive effect or potentiation" type="Increase_Interaction"/><entity charOffset="6:28" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121.e.2" text="Antihypertensive Drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="Other Antihypertensive Drugs   additive effect" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120" text="Antidiabetic Drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122" lineNumber="127" text="Cholestyramine and Colestipol Resins   absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="regular"><entity charOffset="53:72" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.0" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="Colestipol Resins   absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="39:49|73:84" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.1" text="absorption is impaired" type="Decrease_Interaction"/><entity charOffset="104:127" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.3" text="anionic exchange resins" type="Drug_Class"><Normalization><RxNorm RxCui="107801"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123" lineNumber="127" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively." type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.5" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.2" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="23:37" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.0" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:58" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.1" text="colestipol resins" type="Drug_Class"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="68:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="92:98|103:113" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.3" text="reduce absorption" type="Decrease_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.5" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.3" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.5" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.3" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124" lineNumber="129" text="Corticosteroids, ACTH   intensified electrolyte depletion, particularly hypokalemia." type="irregular"><entity charOffset="17:21" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.0" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><entity charOffset="0:15" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.1" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="24:57" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.2" text="intensified electrolyte depletion" type="Specific_Interaction"/><entity charOffset="72:83" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.4" text="hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120" text="Antidiabetic Drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121" text="Other Antihypertensive Drugs   additive effect or potentiation."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122" text="Cholestyramine and Colestipol Resins   absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120" text="Antidiabetic Drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121" text="Other Antihypertensive Drugs   additive effect or potentiation."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122" text="Cholestyramine and Colestipol Resins   absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125" lineNumber="131" text="Pressor Amines (e.g. Norepinephrine)   possible decreased response to pressor amines but not sufficient to preclude their use." type="irregular"><entity charOffset="0:14" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.0" text="Pressor Amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Pressor Amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="21:35" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.1" text="Norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="e.g. Norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="48:66" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.3" text="decreased response" type="Decrease_Interaction"/><entity charOffset="70:84" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.5" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="possible decreased response to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><drugClassMembership drug="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.1" drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.0"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.3"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120" text="Antidiabetic Drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121" text="Other Antihypertensive Drugs   additive effect or potentiation."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122" text="Cholestyramine and Colestipol Resins   absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124" text="Corticosteroids, ACTH   intensified electrolyte depletion, particularly hypokalemia."/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125.e.5"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126" lineNumber="133" text="Skeletal Muscle Relaxants, Non depolarizing (e.g. Tubocurarine)   possible increased responsiveness to the muscle relaxant." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="107:122" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.3" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="0-43" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.0" text="Skeletal Muscle Relaxants, Non depolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:43" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.0" text="Skeletal Muscle Relaxants, Non depolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal Muscle Relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="50:62" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.1" text="Tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="e.g. Tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="75:99" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.5" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.1" drugClass="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.0"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.5"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.118.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.119" text="Alcohol, Barbiturates, Or Narcotics   potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.120" text="Antidiabetic Drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.121" text="Other Antihypertensive Drugs   additive effect or potentiation."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.122" text="Cholestyramine and Colestipol Resins   absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.123" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.124" text="Corticosteroids, ACTH   intensified electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.125" text="Pressor Amines (e.g. Norepinephrine)   possible decreased response to pressor amines but not sufficient to preclude their use."/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.126.e.3"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127" lineNumber="135" text="Lithium  should not generally be given with diuretics. " type="regular"><entity charOffset="0:7" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.0" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="44:53" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.1" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="16:38" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.2" text="not generally be given" type="Caution_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.1" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.127.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128" lineNumber="135" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="regular"><entity charOffset="0:15" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.0" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="16:42" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.1" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="46:53" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.4" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.1"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.4"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.3" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.6" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.128.e.4" type="Increase_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129" text="Refer to the package insert for lithium preparations before use of such preparation with olmesartan medoxomil-hydrochlorothiazide." type="negative"><entity charOffset="110:129" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with olmesartan medoxomil-hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="89:109" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.1" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="with olmesartan medoxomil-hydrochlorothiazide." preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.2" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.1" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.0"/><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.2" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.129.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130" lineNumber="137" text="Non-steroidal Anti-inflammatory Drugs   in some patients the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. " type="regular"><entity charOffset="81:118" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" text="non-steroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="123:142|177:184" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.1" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="123:133|160:184" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.3" text="reduce the antihypertensive effects" type="Specific_Interaction"/><entity charOffset="123:133|144:155|177:184" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.5" text="reduce the natriuretic effects" type="Specific_Interaction"/><entity charOffset="188:192|225:234" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.7" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="194:211|225:234" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.8" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="216:234" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.9" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.1"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.9"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.ddi.3"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.8" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.7" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.9" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.9" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.8" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.7" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.130.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131" lineNumber="137" text="Therefore, when olmesartan medoxomil-hydrochlorothiazide tablets and non-steroidal anti-inflammatory agents are used concomitantly, the patients should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="16:64" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.0" text="olmesartan medoxomil-hydrochlorothiazide tablets" type="Drug"><Normalization><mmtx cui="C0386393" phraseText="olmesartan medoxomil-hydrochlorothiazide tablets" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><mmtx cui="C1243315" phraseText="olmesartan medoxomil-hydrochlorothiazide tablets" preferredWord="Oretic Tablets" semType="clnd"/><mmtx cui="C0386393" phraseText="olmesartan medoxomil-hydrochlorothiazide tablets" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><mmtx cui="C1243317" phraseText="olmesartan medoxomil-hydrochlorothiazide tablets" preferredWord="HydroDIURIL Tablets" semType="clnd"/><mmtx cui="C0386393" phraseText="olmesartan medoxomil-hydrochlorothiazide tablets" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><mmtx cui="C1578285" phraseText="olmesartan medoxomil-hydrochlorothiazide tablets" preferredWord="Esidrix Tablets" semType="clnd"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="69:107" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.1" text="non-steroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="non-steroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="155:163" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.2" text="observed" type="Caution_Interaction"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.1" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.131.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.132" text="The usual recommended starting dose of BENICAR  (olmesartan medoxomil) is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. " type="negative"><entity charOffset="39:46" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.132.e.0" text="benicar" type="Biomedical_Entity"><Normalization><mmtx cui="C1122245" phraseText="The usual recommended starting dose of BENICAR" preferredWord="Benicar" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="49:69" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.132.e.1" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="(olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.132.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.132.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137" lineNumber="141" text="For patients with possible depletion of intravascular volume (e.g., patients treated with diuretics, particularly those with impaired renal function), BENICAR  should be initiated under close medical supervision and consideration should be given to use of a lower starting dose (see WARNINGS, Hypotension in Volume- or Salt-Depleted Patients)." type="regular"><entity charOffset="90:99" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="treated with diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="125:148" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.1" text="impaired renal function" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="those with impaired renal function" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="those with impaired renal function" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="151:158" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.2" text="BENICAR" type="Drug"><Normalization><mmtx cui="C1122245" phraseText="BENICAR" preferredWord="Benicar" semType="phsu, orch"/><RxNorm RxCui="327503"/></Normalization></entity><entity charOffset="200:211" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.3" text="supervision" type="Caution_Interaction"/><entity charOffset="258:277" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.5" text="lower starting dose" type="Caution_Interaction"/><entity charOffset="27:60" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.7" text="depletion of intravascular volume" type="SPAN"/><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.ddi.1"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.3"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.ddi.2"><interaction trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.5"><relations><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.7, Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.1" ddi="true" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.2" trigger="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.137.e.5" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.142" text="Therapy with any combination of olmesartan medoxomil and hydrochlorothiazide will be associated with both sets of dose-independent side effects." type="negative"><entity charOffset="32:52" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.142.e.0" text="olmesartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C0386393" phraseText="Therapy with any combination of olmesartan medoxomil" preferredWord="Olmesartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="321064"/></Normalization></entity><entity charOffset="57:76" id="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.142.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.142.e.0" e2="Dailymed.6bbc032a-3cc4-4b1d-8124-1784214a2821.s.142.e.1"/></sentence><positiveExamples number="35"/><negativeExamples number="63"/></document>